Drug Approval | September 11, 2024
USFDA determines inspection classification of VAI for the contract manufacturing facility at Spokane, Washington
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
He will lead the final stages of work to commission the 54,000-square-foot facility and then lead ongoing operations at the site
The company will take all necessary steps to work with USFDA towards earliest remediation of the above facility
These accolades highlight our unwavering commitment to maintaining the highest safety standards
This project is supported by the Irish Government through IDA Ireland
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Lonza Bend (US) upgrades capabilities in early phase clinical manufacturing services with the addition of bottling and labeling equipment
The inspections concluded with no Form 483 observations or significant critical findings
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
The facility was inspected from May 7 to May 17, 2024
Subscribe To Our Newsletter & Stay Updated
